Please assess the completion status of the following clinical trial:

Trial Title: Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Essential hypertension (grade 1-2)~Exclusion Criteria:~* Severe hypertension~* Secondary hypertension~* Grade III/IV hypertensive retinopathy~* Type 1 diabetes~* Cerebrovascular or cardiovascular event during the last 12 months prior to inclusion.~* Pregnant or lactating females~* History of malignancy.~* shift workers~* intolerant to ABPM

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Valsartan (Type: ACTIVE_COMPARATOR): 160 mg/day on awakening
- Enalapril (Type: ACTIVE_COMPARATOR): 10-20 mg/day on awakening

Based on this trial design, predict the completion outcome and termination type (if applicable).